16-29806766-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002383.4(MAZ):c.65G>A(p.Arg22Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000491 in 1,426,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002383.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAZ | NM_002383.4 | c.65G>A | p.Arg22Gln | missense_variant | 1/5 | ENST00000322945.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAZ | ENST00000322945.11 | c.65G>A | p.Arg22Gln | missense_variant | 1/5 | 1 | NM_002383.4 | ||
ENST00000566537.1 | n.503-226C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000135 AC: 2AN: 147772Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000651 AC: 1AN: 153634Hom.: 0 AF XY: 0.0000113 AC XY: 1AN XY: 88446
GnomAD4 exome AF: 0.00000391 AC: 5AN: 1278452Hom.: 0 Cov.: 32 AF XY: 0.00000472 AC XY: 3AN XY: 635496
GnomAD4 genome AF: 0.0000135 AC: 2AN: 147772Hom.: 0 Cov.: 30 AF XY: 0.0000139 AC XY: 1AN XY: 72010
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.65G>A (p.R22Q) alteration is located in exon 1 (coding exon 1) of the MAZ gene. This alteration results from a G to A substitution at nucleotide position 65, causing the arginine (R) at amino acid position 22 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at